Talk of a "Default" Drug Formulary Rattles Industry: CMS Could Move in That Direction for Marketplace Plans After 2019, but the Discussion Has Already Started.
A proposed CMS rule promising to consider a federal default prescription drug benefit after 2019 has startled manufacturers, pharmacy benefit managers, P&T committees, and pharmacies alike. We consider the rationale and potential effects of such a rule.
| Publicado en: | P&T: A Peer-Reviewed Journal for Managed Care & Formulary Management Vol. 43; no. 2; pp. 89 - 111 |
|---|---|
| Autor principal: | |
| Formato: | Journal Article |
| Publicado: |
MediMedia Managed Markets, an ICON Company
Feb2018
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| Sumario: | A proposed CMS rule promising to consider a federal default prescription drug benefit after 2019 has startled manufacturers, pharmacy benefit managers, P&T committees, and pharmacies alike. We consider the rationale and potential effects of such a rule. |
|---|